Jubilant Pharmova Fact Sheet, Jubilant Pharmova Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Jubilant Pharmova Fact Sheet    (JUBOL)


Get Details: We are Bullish on These 3 Little-known Stocks


Here is the latest financial fact sheet of Jubilant Pharmova. For more details, see the Jubilant Pharmova quarterly results and Jubilant Pharmova share price and chart. For a sector overview, read our pharmaceuticals sector report.

JUBILANT PHARMOVA Price History

Price Rs 744.6
Mkt Cap Rs m 118,593
Vol '000 16.0
P/E X 17.1
P/CF X 8.7
EPS (TTM) Rs 43.5
% ch % -0.3
No. of shares m 159.28
% ch week % -2.4
% ch 1-mth % -12.0
% ch 12-mth % 14.8
52 week H/L Rs 1,046.8/630.0
(As on Jun 22, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

JUBILANT PHARMOVA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
JUBILANT PHARMOVA  EQUITY SHARE DATA
High Rs4558301,039898727 
Low Rs138294600617230 
Sales per share (Unadj.) Rs351.9358.9469.5572.0574.7 
Earnings per share (Unadj.) Rs24.336.139.836.256.4 
Diluted earnings per shareRs24.336.139.836.256.4 
Cash flow per share (Unadj.) Rs46.154.465.959.585.4 
Dividends per share (Unadj.) Rs3.003.003.004.505.00 
Adj. dividends per shareRs3.003.003.004.505.00 
Dividend yield (eoy) %1.00.50.40.61.0 
Book value per share (Unadj.) Rs186.2215.7256.6301.9351.8 
Adj. book value per shareRs186.2215.7256.6301.9351.8 
Shares outstanding (eoy) m159.28159.28159.28159.28159.28 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.81.61.71.30.8 
Avg P/E ratio x12.215.620.620.98.5 
P/CF ratio (eoy) x6.410.312.412.75.6 
Price / Book Value ratio x1.62.63.22.51.4 
Dividend payout %12.48.37.512.48.9 
Avg Mkt Cap Rs m47,22789,528130,531120,69176,220 
No. of employees `000NANANANANA 
Total wages/salary Rs m11,25112,30915,55919,26021,277 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
JUBILANT PHARMOVA  INCOME DATA
Net Sales Rs m56,05057,16574,77991,10891,544 
Other income Rs m134249400357474 
Total revenues Rs m56,18357,41475,17991,46692,018 
Gross profit Rs m12,46913,45315,18414,58819,124 
Depreciation Rs m3,4672,9144,1503,7094,619 
Interest Rs m3,7143,4112,8432,1982,874 
Profit before tax Rs m5,4227,3768,5919,03812,105 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,5541,6302,2473,2683,123 
Profit after tax Rs m3,8685,7466,3445,7708,982 
Gross profit margin %22.223.520.316.020.9 
Effective tax rate %28.722.126.236.225.8 
Net profit margin %6.910.18.56.39.8 
JUBILANT PHARMOVA  BALANCE SHEET DATA
Current assets Rs m28,75329,48131,89845,84850,383 
Current liabilities Rs m24,64416,84020,04720,89726,190 
Net working cap to sales %7.322.115.827.426.4 
Current ratio x1.21.81.62.21.9 
Inventory Days Days10101077 
Debtors Days Days6264555152 
Net fixed assets Rs m58,64459,50662,67467,34272,721 
Share capital Rs m155156156159159 
"Free" reserves Rs m29,50734,20040,70847,92955,880 
Net worth Rs m29,66334,35640,86448,08956,039 
Long term debt Rs m30,13235,05030,47842,42937,397 
Total assets Rs m87,39788,98794,572113,190123,104 
Interest coverage x2.53.24.05.15.2 
Debt to equity ratio x1.01.00.70.90.7 
Sales to assets ratio x0.60.60.80.80.7 
Return on assets %8.710.39.77.09.6 
Return on equity %13.016.715.512.016.0 
Return on capital %15.315.516.012.416.0 
Exports to sales %22.00000 
Imports to sales %15.113.616.118.914.8 
Exports (fob) Rs m12,3390000 
Imports (cif) Rs m8,4677,76212,04417,22713,515 
Fx inflow Rs m12,34410,88114,40212,42215,515 
Fx outflow Rs m9,4137,76212,04417,22713,515 
Net fx Rs m2,9313,1192,358-4,8052,000 
JUBILANT PHARMOVA  CASH FLOW
From Operations Rs m 10,989 12,685 13,032 11,215 15,429 
From Investments Rs m -3,125 -4,504 -6,177 -10,118 -3,270 
From Financial Activity Rs m -8,427 -6,859 -9,011 6,574 -10,504 
Net Cashflow Rs m -524 1,172 -2,123 7,612 2,254 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 46.5%
Foreign collaborators 4.2%
Indian inst/Mut Fund 27.0%
FIIs 25.7%
ADR/GDR 0.0%
Free float 49.3%
Shareholders 61,942
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Bhartiagram , Jyotiba Phoolay Nagar, Gajraula - 244223
E-MAIL invstors@jubl.com WEB www.jubl.com
TEL +91-5924-252351-60 FAX 05924-252352
SECTOR PHARMACEUTICALS GROUP Jubilant Bhartia
TR AGENT Alankit Assignments Ltd., 205-208 Anarkali Complex, Jhandewala Extension
AUDITOR K. N. Gutgutia & Co.
CHM: Shyam S. Bhartia COMP SEC: Lalit Jain YEAR OF INC: 1978 BSE CODE: 530019 FV (Rs): 1 DIV YIELD (%): 0.7

Read: JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SHILPA MEDICARE  PHARMAIDS PH  KOPRAN.  THEMIS MEDICARE  PARNAX LAB  

Compare JUBILANT PHARMOVA With:   SHILPA MEDICARE  PHARMAIDS PH  KOPRAN.  THEMIS MEDICARE  PARNAX LAB  

Compare JUBILANT PHARMOVA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

Indian Indices End Flat; Maruti Suzuki and UPL Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity today and ended on a flat note.

Views on news

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

Points to Keep in Mind Before Subscribing to Krishna Institute of Medical Sciences' IPO (Views On News)

Jun 15, 2021

All you need to know about the IPO of Krishna Institute of Medical Sciences.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Laurus Labs Hits New Life High. Up 500%+ in One Year (Views On News)

Jun 8, 2021

Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

More Views on News

Most Popular

My 'Unlock' Investments (Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth (Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

The Most Visible Sign of India's Revival is on Two Wheels (Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

Wednesday's Market Fall Explained (Fast Profits Daily)

Jun 10, 2021

This is why the stock market fell the way it did on Wednesday.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA - PFIZER COMPARISON

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS